Clinical features of actinomycosis A retrospective, multicenter study of 28 cases of miscellaneous presentations

Medicine (United States)

Volumn 95, Issue 24, 2016, Pages

  Bonnefond, Simon ^a   Catroux, Melanie ^b   Melenotte, Clea ^c   Karkowski, Ludovic ^d   Rolland, Ludivine ^e   Trouillier, Sebastien ^f   Raffray, Loic ^a,e  

^a Teaching Hospital of la Réunion   (France)

^b Biology Pharmacy Public Health Pole   (France)

^c TIMONE HOSPITAL   (France)

^d Internal Medicine Unit   (France)

^e Orthopaedic Surgery and Traumatology Department   (France)

^f Centre Hospitalier Henri Mondor   (France)

Author keywords

Actinomyces spp.; Actinomycosis; Differential diagnosis; Immunocompetent; Internal medicine

Indexed keywords

AMOXICILLIN; ANTIINFECTIVE AGENT;

ACTINOMYCOSIS; ADULT; ANTIBIOTIC THERAPY; ARTICLE; BIOPSY; BLOOD CULTURE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOCOMPROMISED PATIENT; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; MIXED INFECTION; NONHUMAN; PRIORITY JOURNAL; TREATMENT DURATION; ACTINOMYCES; AGED; CLINICAL TRIAL; DIAGNOSTIC IMAGING; FRANCE; INCIDENCE; ISOLATION AND PURIFICATION; MICROBIOLOGY; MULTICENTER STUDY; PROGNOSIS; RETROSPECTIVE STUDY; SKIN; TIME FACTOR;

ACTINOMYCES; ACTINOMYCOSIS; ADULT; AGED; ANTI-BACTERIAL AGENTS; BIOPSY; FEMALE; FOLLOW-UP STUDIES; FRANCE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SKIN; TIME FACTORS;

EID: 84976439489     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000003923     Document Type: Article

References (30)

1. Wong VK, Turmezei TD, Weston VC. Actinomycosis. BMJ 2011;343: d6099.
2. Pulverer G, Schütt-Gerowitt H, Schaal KP. Human cervicofacial actinomycoses: microbiological data for 1997 cases. Clin Infect Dis 2003;37:490-7.
3. Könönen E, Wade WG. Actinomyces and related organisms in human infections. Clin Microbiol Rev 2015;28:419-42.
4. Peters BM, Jabra-Rizk MA, Graeme AO, et al. Polymicrobial interactions: impact on pathogenesis and human disease. Clin Microbiol Rev 2012;25:193-213.
5. Jordan HV, Kelly DM, Heeley JD. Enhancement of experimental actinomycosis in mice by Eikenella corrodens. Infect Immun 1984;46: 367-71.
6. Smego RA, Foglia G. Actinomycosis. Clin Infect Dis 1998;26:1255-61.
7. Oostman O, Smego RA. Cervicofacial actinomycosis: diagnosis and management. Curr Infect Dis Rep 2005;7:170-4.
8. Garner JP, Macdonald M, Kumar PK. Abdominal actinomycosis. Int J Surg Lond Engl 2007;5:441-8.
9. Steininger C, Willinger B. Resistance patterns in clinical isolates of pathogenic Actinomyces species. J Antimicrob Chemother 2016;71: 422-7.
10. Duvignaud A, Ribeiro E, Moynet D, et al. Cervical spondylitis and spinal abscess due to Actinomyces meyeri. Braz J Infect Dis 2014;18:106-9.
11. Constans J, Barcat D, Skopinski S, et al. Thoracic actinomycosis sensitive to amoxicillin. Rev Médecine Interne Fondée Par Société Natl Francaise Médecine Interne 2002;23:1030-1.
12. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992;101: 1644-55.
13. Kim SR, Jung LY, Oh I-J, et al. Pulmonary actinomycosis during the first decade of 21st century: cases of 94 patients. BMC Infect Dis 2013; 13:216.
14. Song J-U, Park HY, Jeon K, et al. Treatment of thoracic actinomycosis: a retrospective analysis of 40 patients. Ann Thorac Med 2010;5:80-5.
15. Park JY, Lee T, Lee H, et al. Multivariate analysis of prognostic factors in patients with pulmonary actinomycosis. BMC Infect Dis 2014;14:10. doi:10. 1186/1471-2334-14-10.
16. Choi M-M, Baek JH, Beak JH, et al. Clinical features of abdominopelvic actinomycosis: report of twenty cases and literature review. Yonsei Med J 2009;50:555-9.
17. Smego RA. Actinomycosis of the central nervous system. Rev Infect Dis 1987;9:855-65.
18. Acevedo F, Baudrand R, Letelier LM, et al. Actinomycosis: a great pretender. Case reports of unusual presentations and a review of the literature. Int J Infect Dis 2008;12:358-62.
19. Cabot RC, Rosenberg ES, Harris NL, et al. Case 25-2015: an 8-year-old girl with a chest-wall mass and a pleural effusion. N Engl J Med 2015;373:657-67.
20. Pierre I, Zarrouk V, Noussair L, et al. Invasive actinomycosis: surrogate marker of a poor prognosis in immunocompromised patients. Int J Infect Dis 2014;29:74-9.
21. Wilson JW. Nocardiosis: updates and clinical overview. Mayo Clin Proc 2012;87:403-7.
22. Cheung MK, Lam WY, Fung WYW, et al. Sputum Microbiota in Tuberculosis as Revealed by 16S rRNA Pyrosequencing. PLoS One 2013;8:e54574.
23. Cintron JR, Del Pino A, Duarte B, et al. Abdominal actinomycosis. Dis Colon Rectum 1996;39:105-8.
24. Fichte S, Brodhun M, Göttinger S, et al. Vertebral and pulmonary actinomycosis mimicking metastatic lung cancer. J Neurol Surg Part Cent Eur Neurosurg 2013;74(Suppl 1):e188-92.
25. Weisshaupt C, Hitz F, Albrich WC, et al. Pulmonary actinomycosis and Hodgkin's disease: when FDG-PET may be misleading. BMJ Case Rep 2014;2014: pii: bcr2014206034. doi: 10.1136/bcr-2014-206034.
26. Sudhakar SS, Ross JJ. Short-term treatment of actinomycosis: two cases and a review. Clin Infect Dis 2004;38:444-7.
27. Pézier TF, Kastrinidis N, Widmer G-M, et al. Fatally invasive actinomycosis masquerading as a tonsillar carcinoma. Head Neck 2014;36:E129-30.
28. Kolbert CP, Persing DH. Ribosomal DNA sequencing as a tool for identification of bacterial pathogens. Curr Opin Microbiol 1999;2: 299-305.
29. Ng LSY, Sim JHC, Eng LC, et al. Comparison of phenotypic methods and matrix-assisted laser desorption ionisation time-of-flight mass spectrome-try for the identification of aero-tolerant Actinomyces spp. isolated from soft-tissue infections. Eur J Clin Microbiol Infect Dis 2012;31:1749-52.
30. Seng P, Drancourt M, Gouriet F, et al. Ongoing revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin Infect Dis 2009;49:543-51.